India · Delayed Price · Currency is INR Hester Biosciences Statistics
Total Valuation
NSE:HESTERBIO has a market cap or net worth of INR 17.67 billion. The enterprise value is 19.96 billion.
| Market Cap | 17.67B |
| Enterprise Value | 19.96B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Aug 6, 2025 |
Share Statistics
| Current Share Class | 8.51M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.33% |
| Shares Change (QoQ) | +14.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.99M |
Valuation Ratios
The trailing PE ratio is 47.00.
| PE Ratio | 47.00 |
| Forward PE | n/a |
| PS Ratio | 5.60 |
| PB Ratio | 5.41 |
| P/TBV Ratio | 5.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 53.08 |
| EV / Sales | 6.33 |
| EV / EBITDA | 27.48 |
| EV / EBIT | 35.56 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 3.27 |
| Debt / FCF | n/a |
| Interest Coverage | 10.08 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.90% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.61M |
| Profits Per Employee | 668,932 |
| Employee Count | 562 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:HESTERBIO has paid 105.30 million in taxes.
| Income Tax | 105.30M |
| Effective Tax Rate | 21.42% |
Stock Price Statistics
The stock price has decreased by -14.29% in the last 52 weeks. The beta is 0.12, so NSE:HESTERBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -14.29% |
| 50-Day Moving Average | 1,960.21 |
| 200-Day Moving Average | 1,925.62 |
| Relative Strength Index (RSI) | 55.22 |
| Average Volume (20 Days) | 7,828 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HESTERBIO had revenue of INR 3.15 billion and earned 375.94 million in profits. Earnings per share was 43.07.
| Revenue | 3.15B |
| Gross Profit | 2.24B |
| Operating Income | 518.29M |
| Pretax Income | 491.66M |
| Net Income | 375.94M |
| EBITDA | 681.33M |
| EBIT | 518.29M |
| Earnings Per Share (EPS) | 43.07 |
Balance Sheet
The company has 72.19 million in cash and 2.24 billion in debt, giving a net cash position of -2.16 billion.
| Cash & Cash Equivalents | 72.19M |
| Total Debt | 2.24B |
| Net Cash | -2.16B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.27B |
| Book Value Per Share | 369.41 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.88%, with operating and profit margins of 16.43% and 11.92%.
| Gross Margin | 70.88% |
| Operating Margin | 16.43% |
| Pretax Margin | 15.59% |
| Profit Margin | 11.92% |
| EBITDA Margin | 21.60% |
| EBIT Margin | 16.43% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 0.33%.
| Dividend Per Share | 7.00 |
| Dividend Yield | 0.33% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.33% |
| Shareholder Yield | -3.00% |
| Earnings Yield | 2.13% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |